Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erberto Carluccio

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 5, 2025
Strain Reversus Sign: Diagnostic Role and Correlation With Cardiac Magnetic Resonance Findings in Constrictive PericarditisFabio Fazzari, Francesco Cannata, Luigi Tassetti, et al.
International Journal of Cardiology|January 9, 2022
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic studyErberto Carluccio, Frank L Dini, Roberto Bitto, et al.
ESC Heart Failure|February 5, 2022
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartanFrank L Dini, Erberto Carluccio, Roberto Bitto, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|January 1, 2026
Predicting Exercise Pulmonary Hypertension: The RIGHT-NET Machine Learning model A Pilot StudyFrancesco Ferrara, Rossana Castaldo, Luna Gargani, et al.
International Journal of Cardiology|August 2, 2025
Characteristics of patients with suspected cardiac amyloidosis in Tuscany and Umbria: Insights from the cardiac amyloidosis RegistRY (CARRY)Vincenzo Castiglione, Olena Chubuchna, Giulia Elena Mandoli, et al.
ESC Heart Failure|November 30, 2022
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic RegistryGiulia Elena Mandoli, Maria Concetta Pastore, Alberto Giannoni, et al.
European Heart Journal Open|August 3, 2022
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian registerMaria Concetta Pastore, Giulia Elena Mandoli, Alberto Giannoni, et al.
European Journal of Heart Failure|June 26, 2024
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registryRiccardo M Inciardi, Muthiah Vaduganathan, Carlo M Lombardi, et al.
ESC Heart Failure|February 5, 2025
Implementation of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction (OpTIMa-HF Registry)Stefania Paolillo, Christian Basile, Federica Marzano, et al.
European Journal of Heart Failure|December 18, 2025
Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registryRiccardo M Inciardi, Maurizio Volterrani, Gianluigi Savarese, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 5, 2025
Strain Reversus Sign: Diagnostic Role and Correlation With Cardiac Magnetic Resonance Findings in Constrictive PericarditisFabio Fazzari, Francesco Cannata, Luigi Tassetti, et al.
International Journal of Cardiology|January 9, 2022
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic studyErberto Carluccio, Frank L Dini, Roberto Bitto, et al.
ESC Heart Failure|February 5, 2022
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartanFrank L Dini, Erberto Carluccio, Roberto Bitto, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|January 1, 2026
Predicting Exercise Pulmonary Hypertension: The RIGHT-NET Machine Learning model A Pilot StudyFrancesco Ferrara, Rossana Castaldo, Luna Gargani, et al.
International Journal of Cardiology|August 2, 2025
Characteristics of patients with suspected cardiac amyloidosis in Tuscany and Umbria: Insights from the cardiac amyloidosis RegistRY (CARRY)Vincenzo Castiglione, Olena Chubuchna, Giulia Elena Mandoli, et al.
ESC Heart Failure|November 30, 2022
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic RegistryGiulia Elena Mandoli, Maria Concetta Pastore, Alberto Giannoni, et al.
European Heart Journal Open|August 3, 2022
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian registerMaria Concetta Pastore, Giulia Elena Mandoli, Alberto Giannoni, et al.
European Journal of Heart Failure|June 26, 2024
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registryRiccardo M Inciardi, Muthiah Vaduganathan, Carlo M Lombardi, et al.
ESC Heart Failure|February 5, 2025
Implementation of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction (OpTIMa-HF Registry)Stefania Paolillo, Christian Basile, Federica Marzano, et al.
European Journal of Heart Failure|December 18, 2025
Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registryRiccardo M Inciardi, Maurizio Volterrani, Gianluigi Savarese, et al.
Pageof 10